Heritability of features of the insulin resistance syndrome in a community-based study of healthy families

Diabetic Medicine

Volumn 19, Issue 12, 2002, Pages 994-999

  Freeman, Mark S ^a,c   Mansfield, M W ^a   Barrett, J H ^b   Grant, P J ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^c LEEDS GENERAL INFIRMARY   (United Kingdom)

Author keywords

Families; Genetics; Heritability; Insulin resistance

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLASMINOGEN ACTIVATOR INHIBITOR 1; TISSUE PLASMINOGEN ACTIVATOR; TRIACYLGLYCEROL;

ADULT; AGE; ANTHROPOMETRY; ARTICLE; BODY MASS; COMMUNITY; CONTROLLED STUDY; EUROPE; FAMILY; FEMALE; FIBRINOLYSIS; GENETIC TRAIT; GENOTYPE; HERITABILITY; HUMAN; INSULIN RESISTANCE; MALE; NORMAL HUMAN; SEX; ADOLESCENT; BLOOD; BODY CONSTITUTION; CHILD; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED;

ADOLESCENT; ADULT; BODY CONSTITUTION; CHILD; CHOLESTEROL, LDL; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INSULIN RESISTANCE; MALE; MIDDLE AGED; PLASMINOGEN ACTIVATOR INHIBITOR 1; TRIGLYCERIDES;

EID: 0036460122     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-5491.2002.00843.x     Document Type: Article

References (37)

1. Reaven GM. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595-1607.
2. Lindahl B, Asplund K, Eliasson M, Evrin P-E. Insulin resistance syndrome and fibrinolytic activity: The northern Sweden MONICA study. Int J Epidemiol 1996; 25: 291-299.
3. Stewart MW, Humphriss DB, Berrish TS, Barriocanal LA, Trajano LR, Alberti KG et al. Features of syndrome X in first-degree relatives of NIDDM patients. Diabetes Care 1995; 18: 1020-1022.
4. Laws A, Stefanick ML, Reaven GM. Insulin resistance and hypertriglyceridaemia in nondiabetic relatives of patients with non-insulin dependent diabetes mellitus. J Clin Endocrinol Metab 1989; 69: 343-347.
5. Martin BC, Warram JC, Rosner B, Rich SS, Soeldner JS, Kolewski AS. Familial clustering of insulin sensitivity. Diabetes 1992; 41: 850-854.
6. Mayer EJ, Newman B, Austin MA, Zhang D, Quesenberry CPJ, Edwards K et al. Genetic and environmental influences on insulin levels and the insulin resistance syndrome: An analysis of women twins. Am J Epidemiol 1996; 143: 323-332.
7. Schumacher MC, Hasstedt SJ, Hunt SC, Williams RR, Elbein SC. Major gene effect for insulin levels in familial NIDDM pedigrees. Diabetes 1991; 41: 416-423.
8. Mitchell BD, Kammerer CM, Blangero J, Mahaney MC, Rainwater DL, Dyke Bet al. Genetic and environmental contributions to cardiovascular risk factors in Mexican Americans. The San Antonio Family Heart Study. Circulation 1996; 94: 2159-2170.
9. Berenson GS, Srinivasan SR, Nicklas TA. Atherosclerosis: A nutritional disease of childhood. Am J Cardiol 1998; 82: 22T-29T.
10. Barker DJ. In utero programming of chronic disease. Clin Sci 1998; 95: 115-128.
11. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: Insulin resistance and B-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419.
12. Margaglione M, Grandone E, Cappucci G, Collaizzo D, Giuliani N, Vecchione Get al. An alternative method for PAI-1 promotor polymorphism (4G/5G) typing. Thromb Haemostasis 1997; 77: 605-606.
13. Lynch M, Walsh B.Genetics and Analysis of Quantitative Traits, 1st edn. Sunderland, MA: Sinauer Associates Inc., 1998.
14. Almasy L, Blangero J. Multipoint quantitative-trait linkage analysis in general pedigrees.Am J Human Genet 1998; 62: 1198-1211.
15. Dawson SJ, Hamsten A, Wiman B, Henney A, Humphries S. Genetic variation at the plasminogen activator inhibitor-1 locus is associated with altered levels of plasma plasminogen activator inhibitor-1 activity. Arter Thromb 1991; 11: 183-190.
16. Edwards KL, Newman B, Mayer E, Selby JV, Krauss RM, Austin MA. Heritability of factors of the insulin resistance syndrome in women twins. Genetic Epidemiol 1997; 14: 241-253.
17. Snieder H, Boomsma DI, van Doornen LJ, Neale MC. Bivariate genetic analysis of fasting insulin and glucose levels. Genetic Epidemiol 1999; 16: 426-446.
18. Humphriss DB, Stewart MW, Berrish TS, Barriocanal LA, Trajano LR, Ashworth LA, et al. Multiple metabolic abnormalities in normal glucose tolerant relatives of NIDDM families. Diabetologia 1997; 40: 1185-1190.
19. Mitchell BD, Kammerer CM, Mahaney MC, Blangero J, Comuzzie AG, Atwood LD, et al. Genetic analysis of the IRS. Pleiotropic effects of genes influencing insulin levels on lipoprotein and obesity measures. Arteriosclerosis, Thrombosis Vascular Biol 1996; 16:281-288.
20. Haffner SM, Stern MP, Hazuda HP, Pugh JA, Patterson JK. Hyper-insulinaemia in a population at high risk for non-insulin dependent diabetes mellitus. N Engl J Med 1986; 315: 220-224.
21. Hsueh WC, Mitchell BD, Aburomia BA, Pollin T, Sakul H, Ehm MG et al. Diabetes in the Old Order Amish-Characterisation and heritability analysis of the Amish Family Diabetes Study. Diabetes Care 2000; 23: 595-601.
22. Farooqi I, Beevers DG, Lip GY. Insulin resistance, high prevalence of diabetes, and cardiovascular risk in immigrant Asians. Br Heart J 1995; 73: 584.
23. Dhawan J, Bray CL, Warburton R, Ghambhir D, Morris J. Insulin resistance, high prevalence of diabetes, and cardiovascular risk in immigrant Asians. Genetic or environmental effect? Br Heart J 1994; 72: 413-421.
24. Juhan-Vague I, Alessi MC, Vague P. Increased plasma plasminogen activator inhibitor 1 levels. A possible link between insulin resistance and atherothrombosis. Diabetologia 1991; 34: 457-462.
25. Henry M, Tregouet DA, Alessi MC, Aillaud MF, Visvikis S, Siest G et al. Metabolic determinants are much more important than genetic polymorphisms in determining the PAI-1 activity and antigen plasma concentrations: A family study with part of the Stanislas Cohort. Arteriosclerosis, Thrombosis Vascular Biol 1998; 18: 84-91.
26. Pankow JS, Folsom A, Province MA, Rao DC, Williams RR, Eckfeldt J et al. Segregation analysis of plasminogen activator inhibitor-1 and fibrinogen levels in the NHLBI Family Heart Study. Arteriosclerosis, Thrombosis, Vascular Biol 1998; 18: 1559-1567.
27. Hong Y, Pedersen NL, Egberg N, de Faire U. Moderate genetic influences on plasma levels of plasminogen activator inhibitor-1 and evidence of genetic and environmental influences shared by plasminogen activator inhibitor-1, triglycerides, and body mass index. Arteriosclerosis, Thrombosis Vascular Biol 1995; 17: 2776-2782.
28. Dawson SJ, Winman B, Hamsten A, Green F, Humphries S, Henney AM. The two allele sequences of a common polymorphism in the promotor of plasminogen activator inhibitor-1 (PAI-1) gene respond differently to interleukin-1 in HepG2 cells. J Biol Chem 1993; 268: 10739-10745.
29. Eriksson P, Nilsson L, Karpe F, Hamsten A. Very-low-density lipoprotein response element in the promoter region of the human plasminogen activator inhibitor-1 gene implicated in the impaired fibrinolysis of hypertriglyceridemia. Arteriosclerosis, Thrombosis Vascular Biol 1998; 18: 20-26.
30. Ossei-Gerning N, Mansfield MW, Stickland MH, Wilson IJ, Grant PJ. Plasma activator inhibitor-1 promotor 4G/5G genotype and plasma levels in relation to a history of myocardial infarction in patients characterised by coronary angiography. Arteriosclerosis, Thrombosis Vascular Biol 1997; 17: 33-37.
31. Ye S, Green FR, Scarabin P-Y, Nicaud V, Bara L, Dawson SJet al. The 4G/5G genetic polymorphism in the promotor of the plasmino-gen activator-1 (PAI-1) gene is associated with differences in plasma PAI-1 activity but not with risk of myocardial infarction in the ECTIM Study. Thromb Haemost 1995; 74: 837-841.
32. Ridker PM, Vaughen DE, Stampfer MJ, Manson JE, Hennekens CH. Endogenous tissue-type plasminogen activator and the risk of myocardial infarction. Lancet 1993; 341: 1165-1168.
33. Ridker PM, Hennekens CH, Stampfer MJ, Manson JE, Vaughen DE. Prospective study of endogenous tissue-type plasminogen activator inhibitor and risk of stroke. Lancet 1993; 341: 1165-1168.
34. Jern C, Ladenvall P, Wall U, Jern S. Gene polymorphism of t-PA is associated with forearm vascular release rate of t-PA. Arteriosclerosis, Thrombosis Vascular Biol 1999; 19: 454-459.
35. Donahue R, Abott R, Bloom E, reed D, Yano K. Central obesity and coronary heart disease in men.Lancet 1987; i: 821-824.
36. Frankel S, Elwood P, Sweetnam P, Yarnell J, Smith GD. Birthweight, body-mass index in middle age, and incident coronary heart disease. Lancet 1996; 348: 1478-1480.
37. Demerath E, Czerwinski S, Siervogel RM, Towne B. Fetal growth and heritability of fasting insulin concentrations in healthy adults. Genetic Epidemiol 2000; 19: 245.